Literature DB >> 23306767

Biologic grafted repair of urethrovaginal fistula and concomitant synthetic sling.

Aimee L Smith1, G Willy Davila.   

Abstract

The utilization of a biologic graft interposition allows for a successful fistula repair and concomitant synthetic sling without an increase in complications.

Entities:  

Mesh：

Year:  2013        PMID： 23306767     DOI： 10.1007/s00192-012-1996-4

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN： 0937-3462            Impact factor:   2.894


  5 in total

1.  Management of urethrovaginal fistulas.

Authors:  Dmitri Y Pushkar; Vladimir V Dyakov; John W Kosko; Gevorg R Kasyan
Journal:  Eur Urol       Date:  2006-08-15       Impact factor: 20.096

2.  Stress urinary incontinence after delayed primary closure of genitourinary fistula: a technique for surgical management.

Authors:  Marcus P Carey; Judith T Goh; Michelle M Fynes; Christine J Murray
Journal:  Am J Obstet Gynecol       Date:  2002-05       Impact factor: 8.661

3.  Current practices in treatment of female genital fistula: a cross sectional study.

Authors:  Steven D Arrowsmith; Joseph Ruminjo; Evelyn G Landry
Journal:  BMC Pregnancy Childbirth       Date:  2010-11-10       Impact factor: 3.007

4.  Prevention of residual urinary incontinence following successful repair of obstetric vesico-vaginal fistula using a fibro-muscular sling.

Authors:  Andrew Browning
Journal:  BJOG       Date:  2004-04       Impact factor: 6.531

5.  Tension-free vaginal tape sling with a porcine interposition graft in an irradiated patient with a past history of a urethrovaginal fistula and urethral mesh erosion: a case report.

Authors:  Joye Lowman; Robert D Moore; John R Miklos
Journal:  J Reprod Med       Date:  2007-06       Impact factor: 0.142
  5 in total
  1 in total

1.  Urethrovaginal fistulae associated with tension-free vaginal tape procedures: a clinical challenge.

Authors:  Christl Reisenauer; Julian Janowitz; Diethelm Wallwiener; Markus Huebner
Journal:  Int Urogynecol J       Date:  2013-09-13       Impact factor: 2.894
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.